Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photo Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108707101B details a metal-free photocatalytic route to 3-formyl-2-indolinones. Offers mild conditions and high efficiency for pharmaceutical intermediate manufacturing.
Novel metal-free asymmetric deuteration method using D2O. High enantioselectivity for pharma intermediates. Cost-effective supply chain solution.
Patent CN111606785B details a green, Pd-free method for aryl internal alkynes using copper catalysis and visible light, offering significant cost and supply chain advantages.
Patent CN118684552A enables direct trifluoromethylation of electron-deficient rings at room temperature. Discover cost-effective supply chain solutions.
Patent CN112142796A details a mild synthesis of isoquinolinone derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel photoredox method for alpha,alpha-difluoro-beta-carbonyl sulfones using visible light, offering mild conditions and broad substrate scope for pharma intermediates.
Patent CN110818584B reveals a metal-free visible light method for synthesizing alpha,beta-unsaturated amides, offering cost reduction and scalable pharmaceutical intermediate manufacturing.
Novel green synthesis method for alpha-bromo-aromatic ketones using Ru(bpy)3Cl2 photocatalyst, offering high selectivity and mild conditions for pharmaceutical intermediates.
Patent CN114773294A reveals a metal-free route for ebselen compounds. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity intermediates.
Patent CN115583919B reveals a green photocatalytic route for high-purity pharmaceutical intermediates. Discover cost reduction and scalable supply chain advantages.
Novel visible light catalysis method for indol-3-one derivatives. Offers mild conditions and high yield for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN105949079A enables green synthesis of pharmaceutical intermediates. Visible light catalysis ensures high purity and supply chain reliability for global buyers.
Patent CN110963900A details a metal-free oxidative decarboxylation method using 4CzIPN and air, offering a green route for high-purity pharmaceutical intermediates manufacturing.
Patent CN110698369B reveals a mild visible-light method for synthesizing arylacetylene alkyl sulfones using alkyl fluoroborates, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN114315894B discloses a novel nickel-catalyzed synthesis of chiral alpha-aryl phosphates. This method offers mild conditions, high enantioselectivity, and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN119143756A enables green photocatalytic synthesis. Offers significant cost reduction and scalable supply chain solutions for high-purity antiviral pharmaceutical intermediates globally.
Patent CN115745822A enables green visible light synthesis of N-formyl amides using copper catalysis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN106467481A enables green synthesis of indole-3-aryl ketones. Visible light catalysis reduces costs and ensures reliable pharmaceutical intermediates supplier continuity.
Patent CN113754631B reveals a mild, regioselective method for heteroaryl indoles using visible light, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115745842B enables green aromatic carbamate synthesis using CO2. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.